Loading...

Elissa Ozanne, PhD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentSurgery
Address3333 Calif. St,Laurel Heights
San Francisco CA 94118
Phone415-476-1942
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Evaluating a decision aid for breast cancer prevention: a pilot trial
    NIH/NCI R21CA141097Mar 1, 2010 - Feb 28, 2013
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Newhall K, Albright B, Tosteson A, Ozanne E, Trus T, Goodney PP. Cost-effectiveness of prophylactic appendectomy: a Markov model. Surg Endosc. 2017 Jan 11. PMID: 28078461.
      View in: PubMed
    2. Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne E, Greenberg CC, Frank ES, Schrag D. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. JAMA Oncol. 2017 Jan 01; 3(1):101-104. PMID: 27442038.
      View in: PubMed
    3. Ozanne E, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. Am J Surg. 2016 Jun 12. PMID: 27421187.
      View in: PubMed
    4. Cohan JN, Ozanne E, Sewell JL, Hofer RK, Mahadevan U, Varma MG, Finlayson E. A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study. Dis Colon Rectum. 2016 Jun; 59(6):520-8. PMID: 27145309.
      View in: PubMed
    5. Barnes AJ, Hanoch Y, Miron-Shatz T, Ozanne E. Tailoring risk communication to improve comprehension: Do patient preferences help or hurt? Health Psychol. 2016 Sep; 35(9):1007-16. PMID: 27183307.
      View in: PubMed
    6. Barlow DR, Higgins BT, Ozanne E, Tosteson AN, Pearson AM. Cost Effectiveness of Operative Versus Non-Operative Treatment of Geriatric Type-II Odontoid Fracture. Spine (Phila Pa 1976). 2016 Apr; 41(7):610-7. PMID: 27018900.
      View in: PubMed
    7. Ozanne E, Schneider KH, Soeteman D, Stout N, Schrag D, Fordis M, Punglia RS. onlineDeCISion.org: a web-based decision aid for DCIS treatment. Breast Cancer Res Treat. 2015 Nov; 154(1):181-90. PMID: 26475704.
      View in: PubMed
    8. Winn K, Ozanne E, Sepucha K. Measuring patient-centered care: An updated systematic review of how studies define and report concordance between patients' preferences and medical treatments. Patient Educ Couns. 2015 Jul; 98(7):811-21. PMID: 25846191.
      View in: PubMed
    9. Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne E, Elwyn G. Correction: the psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2015; 17(2):e32. PMID: 25667387; PMCID: PMC4353887.
    10. Howe R, Miron-Shatz T, Hanoch Y, Omer ZB, O'Donoghue C, Ozanne E. Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation. J Genet Couns. 2015 Oct; 24(5):744-51. PMID: 25519004.
      View in: PubMed
    11. Hanoch Y, Miron-Shatz T, Rolison JJ, Ozanne E. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy. Psychooncology. 2014 Oct; 23(10):1142-8. PMID: 24733657.
      View in: PubMed
    12. Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur C. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):84-90. PMID: 24681073; PMCID: PMC4227952 [Available on 01/01/16].
    13. Esserman LJ, Alvarado MD, Howe RJ, Mohan AJ, Harrison B, Park C, O'Donoghue C, Ozanne E. Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? Breast Cancer Res Treat. 2014 Apr; 144(2):371-8. PMID: 24584875; PMCID: PMC3949013.
    14. O'Donoghue C, Eklund M, Ozanne E, Esserman LJ. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med. 2014 Feb 4; 160(3):145. PMID: 24658691; PMCID: PMC4142190.
    15. Walsh T, Barr PJ, Thompson R, Ozanne E, O'Neill C, Elwyn G. Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review. BMJ. 2014; 348:g188. PMID: 24458654; PMCID: PMC3900320.
    16. Ozanne E, Howe R, Omer Z, Esserman LJ. Development of a personalized decision aid for breast cancer risk reduction and management. BMC Med Inform Decis Mak. 2014; 14:4. PMID: 24422989; PMCID: PMC3899602.
    17. Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne E, Elwyn G. The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2014; 16(1):e2. PMID: 24389354; PMCID: PMC3906697.
    18. Bravo C, O'Donoghue C, Kaplan CP, Luce J, Ozanne E. Can mHealth Improve Risk Assessment in Underserved Populations? Acceptability of a Breast Health Questionnaire App in Ethnically Diverse, Older, Low-Income Women. J Health Dispar Res Pract. 2014; 7(4). PMID: 25705576.
      View in: PubMed
    19. Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP. Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt). 2014 May; 23(5):420-7. PMID: 24372085; PMCID: PMC4011422.
    20. Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne E. Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat. 2014 Jan; 143(1):135-40. PMID: 24292868.
      View in: PubMed
    21. Abhyankar P, Volk RJ, Blumenthal-Barby J, Bravo P, Buchholz A, Ozanne E, Vidal DC, Col N, Stalmeier P. Balancing the presentation of information and options in patient decision aids: an updated review. BMC Med Inform Decis Mak. 2013; 13 Suppl 2:S6. PMID: 24625214; PMCID: PMC4044010.
    22. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, King J, Lawson ML, Linder SK, Lipkus I, Ozanne E, Peters E, Timmermans D, Woloshin S. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013; 13 Suppl 2:S7. PMID: 24625237; PMCID: PMC4045391.
    23. Omer ZB, Hwang ES, Esserman LJ, Howe R, Ozanne E. Impact of ductal carcinoma in situ terminology on patient treatment preferences. JAMA Intern Med. 2013 Oct 28; 173(19):1830-1. PMID: 23978843.
      View in: PubMed
    24. Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, Thorsen C, Ozanne E. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2013 Sep; 20(9):2873-80. PMID: 23812769.
      View in: PubMed
    25. Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne E. Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters. Patient Educ Couns. 2013 Oct; 93(1):102-7. PMID: 23768763.
      View in: PubMed
    26. Soeteman DI, Stout NK, Ozanne E, Greenberg C, Hassett MJ, Schrag D, Punglia RS. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst. 2013 Jun 5; 105(11):774-81. PMID: 23644480; PMCID: PMC3776282.
    27. Esserman L, Ozanne E, van't Veer L. Will early detection for breast cancer ever work? Clin Chem. 2013 Jan; 59(1):190-3. PMID: 23193061.
      View in: PubMed
    28. Ozanne E, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes KS. Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):146-9. PMID: 23093547.
      View in: PubMed
    29. Ozanne E, O'Connell A, Bouzan C, Bosinoff P, Rourke T, Dowd D, Drohan B, Millham F, Griffin P, Halpern EF, Semine A, Hughes KS. Bias in the reporting of family history: implications for clinical care. J Genet Couns. 2012 Aug; 21(4):547-56. PMID: 22237666.
      View in: PubMed
    30. Alvarado M, Ozanne E, Esserman L. Overdiagnosis and overtreatment of breast cancer. Am Soc Clin Oncol Educ Book. 2012; e40-5. PMID: 24451829.
      View in: PubMed
    31. Campbell S, Stowe K, Ozanne E. Interprofessional practice and decision support: an organizational framework applied to a mental health setting. J Interprof Care. 2011 Nov; 25(6):423-7. PMID: 22011027.
      View in: PubMed
    32. Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne E, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 2012 Apr 15; 118(8):2021-30. PMID: 21935911; PMCID: PMC3245774.
    33. Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011 Sep; 129(2):607-16. PMID: 21597921; PMCID: PMC4324750.
    34. Ozanne E, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011 Aug; 129(1):165-73. PMID: 21390494.
      View in: PubMed
    35. Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne E, Halpern EF, Gazelle GS. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 2010 Mar; 254(3):793-800. PMID: 20177093; PMCID: PMC2826703.
    36. Ozanne E, Wittenberg E, Garber JE, Weeks JC. Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J. 2010 Jan-Feb; 16(1):38-47. PMID: 19889168.
      View in: PubMed
    37. Drohan B, Ozanne E, Hughes KS. Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J. 2009 Sep-Oct; 15 Suppl 1:S46-55. PMID: 19775330.
      View in: PubMed
    38. Sepucha K, Ozanne E. How to define and measure concordance between patients' preferences and medical treatments: A systematic review of approaches and recommendations for standardization. Patient Educ Couns. 2010 Jan; 78(1):12-23. PMID: 19570647.
      View in: PubMed
    39. Ozanne E, Partridge A, Moy B, Ellis KJ, Sepucha KR. Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53. PMID: 19508141.
      View in: PubMed
    40. Sepucha KR, Ozanne E, Partridge AH, Moy B. Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82. PMID: 19329775.
      View in: PubMed
    41. Braithwaite D, Tammemagi CM, Moore DH, Ozanne E, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 1; 124(5):1213-9. PMID: 19058216.
      View in: PubMed
    42. Ozanne E, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J. 2009 Mar-Apr; 15(2):155-62. PMID: 19292801.
      View in: PubMed
    43. Hur C, Broughton DE, Kong CY, Ozanne E, Richards EB, Truong T, Gazelle GS. Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci. 2009 Oct; 54(10):2207-14. PMID: 19057995; PMCID: PMC3737565.
    44. Ozanne E, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9. PMID: 19047286.
      View in: PubMed
    45. Pandharipande PV, Harisinghani MG, Ozanne E, Specht MC, Hur C, Lee JM, Gazelle GS. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol. 2008 Nov; 191(5):1308-19. PMID: 18941062.
      View in: PubMed
    46. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2008 Oct; 103(10):2432-42. PMID: 18775019; PMCID: PMC3736801.
    47. Silvia KA, Ozanne E, Sepucha KR. Implementing breast cancer decision aids in community sites: barriers and resources. Health Expect. 2008 Mar; 11(1):46-53. PMID: 18275401.
      View in: PubMed
    48. Esserman LJ, Shieh Y, Park JW, Ozanne E. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn. 2007 Sep; 7(5):533-44. PMID: 17892362.
      View in: PubMed
    49. Ozanne E, Annis C, Adduci K, Showstack J, Esserman L. Pilot trial of a computerized decision aid for breast cancer prevention. Breast J. 2007 Mar-Apr; 13(2):147-54. PMID: 17319855.
      View in: PubMed
    50. Sepucha K, Ozanne E, Mulley AG. Doing the right thing: systems support for decision quality in cancer care. Ann Behav Med. 2006 Dec; 32(3):172-8. PMID: 17107289.
      View in: PubMed
    51. Sepucha K, Ozanne E, Silvia K, Partridge A, Mulley AG. An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007 Feb; 65(2):261-9. PMID: 17023138.
      View in: PubMed
    52. Ozanne E, Klemp JR, Esserman LJ. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J. 2006 Mar-Apr; 12(2):103-13. PMID: 16509834.
      View in: PubMed
    53. Esserman LJ, Ozanne E, Dowsett M, Slingerland JM. Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis. Breast Cancer Res. 2005; 7(6):R1153-8. PMID: 16457695; PMCID: PMC1410777.
    54. Ozanne E, Esserman LJ. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):2043-52. PMID: 15598759.
      View in: PubMed
    55. Esserman L, Sepucha K, Ozanne E, Hwang ES. Applying the neoadjuvant paradigm to ductal carcinoma in situ. Ann Surg Oncol. 2004 Jan; 11(1 Suppl):28S-36S. PMID: 15015707.
      View in: PubMed
    56. Holtzman S, Ozanne E, Carone B, Goldstein MK, Steinke G, Timbs J. Decision analysis and Alzheimer disease: three case studies. Genet Test. 1999; 3(1):71-83. PMID: 10464580.
      View in: PubMed
    Elissa's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP